Difference in stroke outcomes by thrombolytic agent, route, or dose?
- Mar 26th, 2014
- Manny Singh
In patients with acute ischemic stroke, do different thrombolytic doses, agents, or routes of administration lead to different outcomes? Two of our editors – Adaira Landry and Alex Koyfman – address this question in a systematic review snapshot in the April 2014 issue of Annals. The fulltext is available here.